Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Driven by SELECT cardiovascular outcomes trial label inclusion and ongoing Phase 3 programs in HFpEF and cardiac rehabilitation settings demonstrating a 20% reduction in MACE events
However, the risk of certain side effects may increase with higher doses
This is the most expensive option on the platform, but it comes with the full regulatory backing of FDA approval
Imagine a product to manage diabetes that has a side-effect of weight loss, what can one ask for My 2 Pennies In todays markets, a single breakthrough therapy can redefine an entire industry
2026 readout
US$ 27.34
US$ 29.84
US$ 20.64
US$ 22.32
US$ 21.86
US$ 21.38
US$ 21.76
US$ 22.17
US$ 22.57
